These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 31286756

  • 21. Insulin Resistance and Free Androgen as Predictors for Ovarian Hyperstimulation Syndrome in Non-PCOS Women.
    Nikbakht R, Zargar M, Moramezi F, Ziafat M, Tabesh H, Sattari AR, Sattari SA.
    Horm Metab Res; 2020 Feb; 52(2):104-108. PubMed ID: 31975364
    [Abstract] [Full Text] [Related]

  • 22. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E, Khristesashvili J, Pkhaladze L, Barbakadze L.
    Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
    [Abstract] [Full Text] [Related]

  • 23. Is anti-Mullerian hormone an indicator of potential polycystic ovary syndrome in prepubertal girls with simple obesity?
    Korkmaz Ö, Gökşen D, Özen S, Darcan Ş.
    Turk J Pediatr; 2016 Feb; 58(4):406-412. PubMed ID: 28276214
    [Abstract] [Full Text] [Related]

  • 24. Insulin Sensitivity Indices in Patients with Polycystic Ovary Syndrome with Different Body Mass Index Categories.
    Shahin L, Hyassat D, Batieha A, Khader Y, El-Khateeb M, Ajlouni K.
    Curr Diabetes Rev; 2020 Feb; 16(5):483-489. PubMed ID: 31441729
    [Abstract] [Full Text] [Related]

  • 25. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Puukka K, Bloigu R, Piltonen T, Tapanainen JS, Morin-Papunen L.
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [Abstract] [Full Text] [Related]

  • 26. Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.
    Tian X, Ruan X, Mueck AO, Wallwiener D, Wang J, Liu S, Yin D, Lu Y, Zhang Y, Wu H.
    Gynecol Endocrinol; 2014 Nov; 30(11):836-9. PubMed ID: 25045796
    [Abstract] [Full Text] [Related]

  • 27. The correlation between serum AMH and HOMA-IR among PCOS phenotypes.
    Wiweko B, Indra I, Susanto C, Natadisastra M, Hestiantoro A.
    BMC Res Notes; 2018 Feb 09; 11(1):114. PubMed ID: 29426356
    [Abstract] [Full Text] [Related]

  • 28. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK.
    Clin Endocrinol (Oxf); 2014 Dec 09; 81(6):899-906. PubMed ID: 25040369
    [Abstract] [Full Text] [Related]

  • 29. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY, Lu LK, Li M, Zhang QL, Ying CM.
    PLoS One; 2018 Dec 09; 13(8):e0203129. PubMed ID: 30153296
    [Abstract] [Full Text] [Related]

  • 30. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.
    Gynecol Endocrinol; 2013 Mar 09; 29(3):242-5. PubMed ID: 23194076
    [Abstract] [Full Text] [Related]

  • 31. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y, Huang R, Sun Y, Yue J, Zheng J, Wang L, Tao T, Ma J, Li S, Liu W.
    Reprod Biol Endocrinol; 2017 Jan 26; 15(1):9. PubMed ID: 28125989
    [Abstract] [Full Text] [Related]

  • 32. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S, Ruan J, Huang W, Tan J, Zhang X, Feng X, Liu D, Fu J, Zhou L, Zhou M.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov 26; 50(11):819-24. PubMed ID: 26887768
    [Abstract] [Full Text] [Related]

  • 33. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Madej P, Owczarek A, Chudek J, Skałba P.
    Clin Endocrinol (Oxf); 2015 Jul 26; 83(1):98-104. PubMed ID: 25440474
    [Abstract] [Full Text] [Related]

  • 34. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov 26; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 35. Anti-Müllerian Hormone Accelerates Pathological Process of Insulin Resistance in Polycystic Ovary Syndrome Patients.
    Li XJ, Wang H, Lu DY, Yu TT, Ullah K, Shi XY, Shen YH, Fei XY, Lin ZY, Huang HF, Lin XH.
    Horm Metab Res; 2021 Aug 26; 53(8):504-511. PubMed ID: 34384107
    [Abstract] [Full Text] [Related]

  • 36. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C, Fanelli F, Pariali M, Zanotti L, Gambineri A, Pasquali R.
    J Clin Endocrinol Metab; 2013 Oct 26; 98(10):E1575-82. PubMed ID: 23928669
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. CORRELATION BETWEEN LEVELS OF HOMOCYSTEINE, ANTI-MÜLLERIAN HORMONE AND INSULIN RESISTANCE IN PCOS PATIENTS WITH RECURRENT MISCARRIAGE.
    Asanidze E, Kristesashvili J, Andguladze S.
    Georgian Med News; 2019 May 26; (290):25-29. PubMed ID: 31322509
    [Abstract] [Full Text] [Related]

  • 40. Anti-Mullerian Hormone and Inhibin B Levels in Obese Boys; Relations with Cardiovascular Risk Factors.
    Buyukinan M, Atar M, Pirgon O, Kurku H, Erdem SS, Deniz I.
    Exp Clin Endocrinol Diabetes; 2018 Sep 26; 126(8):528-533. PubMed ID: 29378377
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.